Education

Peptide Research

Jun 8, 2023

Tesamorelin is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH). It’s designed to mimic the effects of naturally occurring GHRH, which stimulates the pituitary gland to release growth hormone. Tesamorelin is mainly studied for its effects on GH regulation and associated metabolic pathways in experimental research models.

What is GHRH?

Growth hormone-releasing hormone (GHRH) is a peptide produced in the hypothalamus. It plays a key role in:

Stimulating growth hormone (GH) release from the pituitary gland

involved in pathways related to protein and lipid metabolism

Participates in cellular signaling processes linked to growth and recovery

Plays a role in circadian regulation of GH release patterns in research settings

Because native GHRH is rapidly broken down in the body, researchers have created more stable analogues like Tesamorelin to allow for extended study.

How Tesamorelin is Being Studied:

Observed Effects on Growth Hormone Secretion

Tesamorelin binds to GHRH receptors on the pituitary gland, triggering a natural increase in GH secretion. In lab settings, this has allowed researchers to examine the downstream effects of elevated GH, such as changes in lipid metabolism and muscle development.

Effects on Visceral Adipose Tissue

One of the most studied effects of Tesamorelin is its ability to reduce visceral fat, particularly in specific research populations. In multiple trials, Tesamorelin has been associated with measurable decreases in abdominal fat without significant impact on subcutaneous fat.

Observed Effects on Glucose Pathways

Unlike some GH-related peptides that may affect glucose metabolism, Tesamorelin has been observed in some models to preserve or have minimal impact on insulin sensitivity, making it a key subject in metabolic research.

References

All products sold by Direct Peptides are strictly for laboratory research purposes only. They are not intended for human or animal consumption, medical, or therapeutic use. The information provided on this website is for educational and informational purposes only.

Education

Peptide Research

Mar 13, 2024

What is BPC-157?

BPC-157 is a man-made peptide. It’s based on a natural protein found in the stomach. Researchers study it for its potential interactions with biological repair processes in experimental models. One key area of research looks at how BPC-157 works with nitric oxide (NO) — a molecule involved in circulation and tissue response in laboratory research.

(Reference: Sikiric et al., 2010)

What is Nitric Oxide (NO)?

NO is a gas made inside the body. It does several important things:

Mediates vasodilation

Acts as a neurotransmitter

Involved in cellular repair signaling

Contributes to immune system pathways

Too much or too little NO can be a problem, so researchers study how to help keep it balanced.

The effects of BPC-157 on Nitric Oxide

1. Boosts NO-Making Enzymes

BPC-157 was observed to influence eNOS activity in rat models, with correlated changes in vascular function.

(Reference: Vukojević et al., 2013)

2. Balances Nitric Oxide in Recovery

In research on muscle, tendon, and nerve injuries, BPC-157 seemed to restore NO levels — either raising or lowering them as needed. Even when NO production was blocked or overactive, BPC-157 was reported to modulate NO balance under both inhibited and stimulated conditions, with associated effects on tissue response markers. Scientists think this might involve other repair signals like VEGF.

(Reference: Sikiric et al., 2010; Seiwerth et al., 2018)

3. Helps with Blood Vessel Function

In preclinical models of vascular stress, BPC-157 was observed to stabilize NO signaling and maintain vessel integrity markers.

(Reference: Sikiric et al., 2016)

References

Vukojević, J., et al. (2013). Pentadecapeptide BPC 157 enhances NO release and modulates vasomotor tone in rats. Journal of Physiology and Pharmacology, 64(3), 355–365.

Sikiric, P., et al. (2010). Stable gastric pentadecapeptide BPC 157 modulates NO-system and promotes healing. Peptides, 31(9), 1601–1610.

Seiwerth, S., et al. (2018). BPC 157 and its possible mechanisms of action: an overview. Current Pharmaceutical Design, 24(19), 2000–2021.

Sikiric, P., et al. (2016). BPC 157 and blood vessel function: findings from preclinical research. Regulatory Peptides, 234, 16–27.

All products sold by Direct Peptides are strictly for laboratory research purposes only. They are not intended for human or animal consumption, medical, or therapeutic use. The information provided on this website is for educational and informational purposes only.

‹ What is Cagrilintide?

What is Tesamorelin? ›

Education

Peptide Research

Oct 16, 2024

Cagrilintide is a lab-made peptide based on amylin, a naturally occurring peptide that works with insulin. Researchers are investigating its role in signaling pathways related to appetite and metabolism in laboratory models. Studies explore how cagrilintide interacts with central receptors involved in appetite signaling and gastric motility in experimental settings.

What is Amylin?

Amylin is a peptide involved in:

• Influencing gastric emptying rates

• Interacts with satiety signaling pathways

• Postprandial glucose regulation in research models

Because regular amylin breaks down quickly, researchers developed longer-lasting versions like cagrilintide to study these effects more easily.

How Cagrilintide is Being Studied:

1. Effects on Appetite Receptors

In controlled research studies, cagrilintide showed measurable activity at appetite-related receptors, correlating with changes in food intake in the study group. This effect has been observed to alter markers of gastric motility and energy regulation in laboratory investigations.

2. Slows Down Gastric Emptying

Cagrilintide has been shown to slow down how quickly food leaves the stomach. This effect has been linked to better appetite control and steadier energy levels in research settings.

3. Works Well with GLP-1 Analogs

Scientists are also studying cagrilintide with GLP-1 peptides like semaglutide. Preclinical and clinical research is exploring combined use with GLP-1 analogs, where additive effects on metabolic signaling have been observed.

References

All products sold by Direct Peptides are strictly for laboratory research purposes only. They are not intended for human or animal consumption, medical, or therapeutic use. The information provided on this website is for educational and informational purposes only.

Education

Peptide Research

Jan 24, 2024

GHK-Cu stands for glycyl-L-histidyl-L-lysine copper. It’s a small peptide that naturally connects with copper. It has been found in places like plasma and saliva. Scientists have been studying it for many years because of how it may support repair and growth processes in different types of research.Researchers have made lab versions of GHK-Cu to study its effects in areas like skin, hair, tissue recovery, and cellular activity.

What is GHK-Cu known for?

1. Tissue Support and Repair

In lab tests, GHK-Cu has shown potential to help with building new blood vessels, supporting collagen production, and balancing enzymes involved in tissue breakdown and rebuilding.

(Reference: $Maquart et al., 1993/$; $Pickart & Margolina, 2018/$)

2. Skin and Hair Research

GHK-Cu is being studied in cosmetic and dermatology research for how it may affect the skin’s texture and appearance. It has also been looked at for its possible effects on hair quality.

(Reference: $Campiche et al., 2019/$; $Pickart et al., 2015/$)

3. Inflammation and Oxidative Stress

Some studies show that GHK-Cu may help reduce certain signs of inflammation and oxidative stress in research models. It seems to work by influencing how certain genes behave.

4. Nervous System Research

GHK-Cu has also been studied in models related to nerve growth and brain repair. Researchers are interested in how it might affect pathways involved in regeneration and cell signaling.

References

All products sold by Direct Peptides are strictly for laboratory research purposes only. They are not intended for human or animal consumption, medical, or therapeutic use. The information provided on this website is for educational and informational purposes only.

Education

Jun 12, 2024

What Are In Vitro Studies?

In vitro studies are experiments done outside of living organisms — usually in test tubes, petri dishes, or lab equipment. The term “in vitro” means “in glass” in Latin. Researchers use these studies to learn how peptides and other compounds behave at a cellular or molecular level before moving on to animal or human trials.

This kind of research helps scientists understand how a peptide might affect things like protein signaling, tissue regeneration, or inflammation — without needing a full living system.

(Reference: Pampaloni et al., 2007)

How Are In Vitro Studies Used in Peptide Research?

Peptides like BPC-157, GHK-Cu, and Semaglutide are often studied in vitro before any in vivo (in-animal or human) work is considered. These lab studies can help test:

• Cell growth and recovery

• Collagen production

• Wound repair mechanisms

• Antioxidant activity

• Inflammatory responses

Advantages of In Vitro Testing

Controlled Environment

In vitro setups allow researchers to isolate one variable at a time. This means they can precisely measure how a peptide influences a single pathway — like nitric oxide production or growth factor expression.

(Reference: Hartung, 2007)

Early Safety Insights

By observing peptide effects on cultured cells, scientists can gather preliminary safety data and decide if further testing is warranted.

Cost-Effective and Scalable

Compared to live animal studies, in vitro tests are faster and less expensive — ideal for early-stage research.

Limitations to Be Aware Of

In vitro studies don’t replicate the complexity of a full biological system. Just because a peptide activates a response in a petri dish doesn’t guarantee the same effect in a human or animal model. That’s why in vitro studies are only one step in the broader research process.

(Reference: van der Worp et al., 2010)

Common Peptide In Vitro Applications

• Testing cellular repair with BPC-157

• Studying copper-binding and collagen synthesis using GHK-Cu

• Analyzing receptor activity with GLP-1 analogs like Semaglutide or Tirzepatide

References

Pampaloni, F., Reynaud, E.G., & Stelzer, E.H. (2007). The third dimension bridges the gap between cell culture and live tissue. Nature Reviews Molecular Cell Biology, 8(10), 839–845.

Hartung, T. (2007). Food for thought… on cell culture. ALTEX, 24(3), 143–147.

van der Worp, H.B., et al. (2010). Can animal models of disease reliably inform human studies? PLoS Medicine, 7(3), e1000245.

All products sold by Direct Peptides are strictly for laboratory research purposes only. They are not intended for human or animal consumption, medical, or therapeutic use. The information provided on this website is for educational and informational purposes only.

‹ Semax vs. N-Acetyl Semax Amidate

What is GHK-Cu? ›

Education

Peptide Research

Aug 18, 2024

What Is Semax?

Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) derived from an ACTH(4–7) fragment extended by Pro-Gly-Pro. It has been examined in lab settings for effects on neural pathways and enzyme interactions, and its sequence/chemistry are well described in the peptide literature. $(Reference: Magrì et al., 2016)/$

What Is N-Acetyl Semax Amidate?

N-Acetyl Semax Amidate (often written Ac-Semax-NH₂) features the same seven-amino-acid backbone as Semax but with N-terminal acetylation and C-terminal amidation. These terminal caps are common peptide modifications explored to affect stability and handling in experimental systems. $(Reference: Magrì et al., 2016)/$

How Do They Differ Chemically?

Backbone: Identical sequence (MEHFPGP). $(Reference: Magrì et al., 2016)/$

Termini: Semax has free N- and C-termini; N-Acetyl Semax Amidate is acetylated (N-cap) and amidated (C-cap), a change often investigated to influence enzymatic susceptibility and physicochemical behavior in assays. $(Reference: Magrì et al., 2016)/$

How Have They Been Studied in Research?

Semax (foundational studies): Early work characterized sequence, enzyme sensitivity, and degradation pathways in blood/serum, indicating prominent roles for aminopeptidases in N-terminal cleavage of Semax and related fragments. $(Reference: Potaman et al., 1991; 1993)/$ $(link 2)/$

N-Acetyl Semax Amidate (terminally modified analog): Acetylating Semax’s N-terminus alters metal-ion coordination and downstream properties in vitro; this has been used as a model to study how terminal capping can change peptide behavior in cell and coordination assays. $(Reference: Magrì et al., 2016)/$

Delivery/stability context (literature overview): Reviews of intranasal peptide research and peptide-delivery strategies note terminal modifications (including N-acetylation) and formulation approaches as ways to explore stability during experimental handling; some reports specifically mention acetylated Semax among promising candidates for such work. $(Reference: Shevchenko et al., 2019)/$

Advantages in Laboratory Context

Defined Backbone With a Well-Documented Parent Peptide

Semax’s sequence and degradation pathways are described across multiple studies, providing a clear baseline for comparative experiments. $(Reference: Potaman et al., 1991; 1993)/$ $(link 2)/$

Terminal Modifications Enable Controlled Comparisons

Using N-Acetyl Semax Amidate allows researchers to isolate the impact of capping on coordination chemistry or assay stability without changing the primary sequence. $(Reference: Magrì et al., 2016)/$

Method Development

Reviews highlight terminal modification as one of several knobs (alongside carriers and excipients) for exploring peptide handling and recovery in in vitro or model-delivery setups. $(Reference: Shevchenko et al., 2019)/$

Limitations to Keep in Mind

Enzymatic Susceptibility (Parent Peptide): Semax is susceptible to aminopeptidases and other enzymes; experimental design often accounts for this during incubations or biological-media exposure. $(Reference: Potaman et al., 1991; 1993)/$ $(link 2)/$

Altered Interactions (Modified Analog): N-terminal acetylation can change metal-binding modes and related readouts, so results may diverge from the parent peptide in specific assays. $(Reference: Magrì et al., 2016)/$

Heterogeneous Literature Footing: Semax has a longer publication history than its acetyl-amidated analog; direct head-to-head datasets are comparatively limited in the public literature. $(Reference: overview across sources above)/$

References

All products sold by Direct Peptides are strictly for laboratory research purposes only. They are not intended for human or animal consumption, medical, or therapeutic use. The information provided on this website is for educational and informational purposes only.

Education

Peptide Research

Sep 1, 2024

What Is AOD-9604?

AOD-9604 is a synthetic peptide fragment derived from the C-terminal end of human growth hormone (hGH). Specifically, it corresponds to amino acids 177–191 of hGH with an added tyrosine for stability. Researchers first developed it to explore how smaller peptide fragments of hGH might influence fat metabolism pathways without engaging the broader hormone system.

How Has AOD-9604 Been Studied in Research?

AOD-9604 has been examined in multiple experimental systems:

In vitro assays to assess receptor interactions, gene expression, and toxicity.

Animal models to study metabolic pathways such as lipid breakdown and receptor regulation.

Human studies to monitor biomarkers like IGF-1, glucose tolerance, and overall safety.

These investigations provide insight into how the fragment behaves biologically, even though results vary depending on the model used.

Observations Reported in Studies

Laboratory and published research on AOD-9604 has reported:

Receptor Pathways – Upregulation of beta-3 adrenergic receptors in adipose tissue has been observed in animal models, suggesting involvement in fat-cell signaling.

IGF-1 Independence – Both animal and human studies consistently show no change in IGF-1 levels, distinguishing AOD-9604 from intact growth hormone.

Safety Markers – Toxicology programs and clinical studies found no genotoxic activity, no antibody formation, and a tolerability profile comparable to placebo groups.

Advantages and Limitations in Experimental Settings

Advantages

Selective Pathway Focus – Allows researchers to study fat metabolism mechanisms without triggering growth-hormone-related pathways.

Safety Data – Extensive testing in vitro, in animals, and in human trials has documented a consistent safety profile.

Multiple Models – The peptide has been evaluated across diverse systems, making it a flexible tool for laboratory research.

Limitations

Mechanism Uncertainty – While certain receptor pathways are implicated, the exact molecular targets remain under investigation.

Translational Gaps – Findings from rodent and cell studies do not always align with results seen in human trials.

Narrow Scope – AOD-9604’s activity appears limited to metabolic pathways, which may restrict broader research applications.

All products sold by Direct Peptides are strictly for laboratory research purposes only. They are not intended for human or animal consumption, medical, or therapeutic use. The information provided on this website is for educational and informational purposes only.

Education

Peptide Research

Jan 7, 2025

What Is NAD+?

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in all living cells. It cycles between oxidized (NAD+) and reduced (NADH) forms, shuttling electrons during cellular reactions. Because it is required for energy production and enzyme activity, NAD+ is considered a central molecule in cellular metabolism.

How Has NAD+ Been Studied?

NAD+ has been examined across multiple levels of research:

In vitro assays have explored how NAD+ interacts with enzymes, such as sirtuins and PARPs.

Animal models have investigated how NAD+ levels change in tissues during aging, stress, or nutrient shifts.

Human studies often measure circulating NAD+ or related metabolites, sometimes in the context of supplementation with precursors like nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN).

Key Roles of NAD+ in Cells

Research has identified several fundamental roles for NAD+:

Energy Production – Serves as a cofactor in glycolysis, the TCA cycle, and oxidative phosphorylation.

DNA Repair – Consumed by PARP enzymes during repair of damaged DNA strands.

Gene Regulation – Provides substrate for sirtuins, which influence chromatin structure and gene expression.

Stress Response – Helps regulate cellular defense systems during oxidative and metabolic stress.

What Researchers Have Observed

Studies over the last two decades have highlighted consistent patterns:

Decline With Age – NAD+ levels are reported to decrease in tissues of animals and humans over time.

Tissue Variability – NAD+ concentrations differ between organs, with high demand in energy-intensive tissues such as muscle, brain, and liver.

Precursor Response – Trials with NR or NMN supplementation in humans have measured increases in NAD+ metabolites, though results vary by dose and duration.

Dynamic Regulation – Environmental stress, diet, and exercise all influence NAD+ turnover, making it a sensitive indicator of metabolic state.

References

All products sold by Direct Peptides are strictly for laboratory research purposes only. They are not intended for human or animal consumption, medical, or therapeutic use. The information provided on this website is for educational and informational purposes only.

Education

Feb 1, 2025

Why Revisit Acetic Acid Synthesis Today?

Acetic acid is a foundational industrial chemical, used in polymers, solvents, and chemical intermediates. Traditional production (e.g. methanol carbonylation) continues to dominate, yet concerns about carbon footprint, energy efficiency, and sustainability have driven new innovation efforts. In 2025, several studies and technologies are emerging that aim to transform how acetic acid is made at scale.

What Are the Recent Innovations?

Recent research focuses on more sustainable, lower-energy, or carbon-utilizing methods. Key trends include:

Green Catalytic Routes: Efforts to tweak or reinvent the classic carbonylation methods (e.g. Cativa/Monsanto variants) to reduce waste and energy consumption. For instance, new simulation-based designs reduce distillation steps and recover reactor heat more efficiently. $(Reference: “Optimization of Acetic Acid Production” paper, 2025)/$

Carbon Capture & Utilization (CCU): Partnerships combining industrial CO₂ emissions and microbial or catalytic conversion into acetic acid, effectively turning waste carbon into a useful feedstock. $(Reference: Key Developments in Acetic Acid Industry, 2025)/$

Photocatalytic CO₂ Reduction: New photocatalyst systems (e.g. chiral mesostructured ZnIn₂S₄) demonstrate exceptionally high selectivity toward acetic acid from CO₂ under light. These systems may signal a shift toward light-driven, low-temperature acetic acid generation. $(Reference: Cui et al., 2025 preprint)/$

Process Intensification & Purity Gains: Researchers are applying process intensification (reducing steps, combining functions) and purity optimization in methanol carbonylation systems. These approaches limit energy usage and reduce separation burdens. $(Reference: Optimization of Acetic Acid Production paper, 2025)/$

What Recent Studies Reported

Recent literature offers several interesting observations from lab and simulation studies:

In the “Win–Win More Sustainable Routes” paper, researchers showed that alternative pathways (e.g. integrating biomass or waste feedstocks) can reach yields competitive with conventional methods if catalyst selectivity is high and separation steps are minimized. $(Reference: Medrano-García et al., 2025)/$

The process optimization study using the Cativa framework demonstrated that by reducing the number of distillation steps from three to two and coupling reactor heat to drive separations, the total energy consumption could drop significantly. $(Reference: Optimization paper, 2025)/$

The ZnIn₂S₄ photocatalyst system achieved a reported acetic acid formation rate of ~962 μmol·g⁻¹·h⁻¹ with ~97.3% selectivity under lab conditions, which is significantly higher than many prior systems. This suggests improved catalyst design and charge transfer path control may unlock scalable photochemical approaches. $(Reference: Cui et al., 2025 preprint)/$

Industry trend analyses indicate that major chemical companies are investing more in CCU-based acetic acid and green pathways to comply with emissions policies. For example, BP and LanzaTech’s collaboration aims to convert CO₂ emissions into acetic acid feedstock using advanced carbon capture technologies. $(Reference: Coherent Market Insights, 2025)/$

How These Innovations May Be Used in Research & Industry

Benchmarking New Catalysts: Researchers can compare novel catalysts (e.g. chiral sulfide systems, dual-site catalysts) against conventional Cativa benchmark to assess tradeoffs in selectivity, stability, and energy cost.

Hybrid Systems: Integrating CCU or photocatalysis with carbonylation (e.g. partial photogenerated acetic acid feeding into conventional units) may offer transitional deployment paths.

Process Design Studies: Energy integration, heat recovery, and simplified separation schemes from recent papers provide case studies for designing pilot plants.

Life-Cycle & Carbon Accounting: The new routes allow researchers to explore production pathways with lower GHG footprints; lifecycle assessments are vital to decide which innovations are truly greener.

References

All products sold by Direct Peptides are strictly for laboratory research purposes only. They are not intended for human or animal consumption, medical, or therapeutic use. The information provided in this blog post is for educational and informational purposes only.

Education

Peptide Research

Mar 23, 2025

What Is Sermorelin?

Sermorelin is a synthetic peptide fragment consisting of the first 29 amino acids of growth hormone–releasing hormone (GHRH). This shortened sequence retains biological activity in stimulating growth hormone pathways, making it a useful compound for laboratory research into endocrine signaling and cell-level responses.

How Has Sermorelin Been Studied?

Sermorelin has been evaluated in various experimental systems designed to measure hormone release and cellular behavior. Researchers have investigated:

In vitro models, examining receptor binding on pituitary cells and downstream signaling cascades.

Animal studies, where peptide administration was linked to changes in growth hormone output and metabolic endpoints.

Human research, often centered on endocrine responses such as growth hormone secretion and associated biomarkers.

Key Laboratory Observations

When focusing on cell proliferation, studies have highlighted a few notable findings:

Pituitary Cell Activation – Sermorelin directly stimulates GHRH receptors on pituitary somatotrophs, leading to cell signaling cascades involving cAMP.

Indirect Effects on Proliferation – While Sermorelin itself is not mitogenic, it influences growth hormone output, which can in turn modulate downstream factors affecting cellular proliferation in different tissues.

Pathway-Specific Outcomes – Research indicates that proliferative effects are context-dependent and may vary between pituitary-derived cells and peripheral models exposed to growth hormone.

Research Applications

Scientists continue to use Sermorelin in experimental settings to explore:

Growth hormone signaling mechanisms in pituitary cells.

Links between peptide-induced hormone release and secondary cellular outcomes, including proliferation.

Comparative models between endogenous GHRH and synthetic fragments.

References

All products sold by Direct Peptides are strictly for laboratory research purposes only. They are not intended for human or animal consumption, medical, or therapeutic use. The information provided on this website is for educational and informational purposes only.